BeOne Medicines Ltd. (ONC)

370.70 +19.22 (+5.47%) USD  |  NASDAQ  |  Oct 15, 11:53
More

BeOne Medicines Total Long Term Debt (Quarterly) : 1.808B for June 30, 2026

Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 1.808B
March 31, 2026 1.893B
December 31, 2025 1.913B
September 30, 2025 1.121B
June 30, 2025 241.90M
March 31, 2025 252.92M
December 31, 2024 245.34M
September 30, 2024 252.38M
June 30, 2024 251.30M
March 31, 2024 245.52M
December 31, 2023 248.45M
September 30, 2023 250.52M
June 30, 2023 254.13M
March 31, 2023 255.33M
December 31, 2022 257.80M
September 30, 2022 254.31M
June 30, 2022 607.85M
March 31, 2022 648.97M
December 31, 2021 247.97M
September 30, 2021 680.90M
June 30, 2021 663.83M
March 31, 2021 624.63M
Date Value
December 31, 2020 548.07M
September 30, 2020 230.45M
June 30, 2020 348.88M
March 31, 2020 283.46M
December 31, 2019 266.53M
September 30, 2019 274.54M
June 30, 2019 266.21M
March 31, 2019 261.14M
December 31, 2018 198.40M
September 30, 2018 195.97M
June 30, 2018 209.75M
March 31, 2018 173.68M
December 31, 2017 164.72M
September 30, 2017 158.35M
June 30, 2017 152.73M
March 31, 2017 17.43M
December 31, 2016 17.28M
September 30, 2016 18.03M
June 30, 2016 10.55M
March 31, 2016 6.214M
December 31, 2015 6.188M
September 30, 2015 6.306M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Basilea Pharmaceutica AG 0.00
Santhera Pharmaceuticals Holding AG 0.00
AC Immune SA 5.085M
CRISPR Therapeutics AG 765.10M
Idorsia Ltd. 1.347B